Lars Erik Larsson
Vorsitzender bei Ellet Assets AB
Profil
Lars Erik Larsson is currently the Chairman at Ellet Assets AB and Fastighets AB.
Olshög.
He is also an Associate Professor at Umea Universitet.
In the past, he worked as the Medical Director at Astra Draco AB, Director at Wntresearch AB, Director at Cantargia AB, Director at Forskarpatent i Syd AB, Director at Cardio Vax LLC, and Senior Partner at TranScrip Partners LLP.
Additionally, Dr. Larsson was the Executive Director & Director-Medical Licensing at AstraZeneca R & D Lund from 1996 onwards.
Aktive Positionen von Lars Erik Larsson
| Unternehmen | Position | Beginn |
|---|---|---|
Ellet Assets AB
 Ellet Assets AB Miscellaneous Commercial ServicesCommercial Services Ellet Assets AB owns and manages real estate properties and securities. The company is headquartered in Lund, Sweden. | Vorsitzender | 07.03.2011 |
| AstraZeneca R & D Lund | Direktor/Vorstandsmitglied | 01.01.1996 |
| Umea Universitet | Corporate Officer/Principal | - |
| Fastighets AB Olshög | Vorsitzender | - |
Ehemalige bekannte Positionen von Lars Erik Larsson
| Unternehmen | Position | Ende |
|---|---|---|
TranScrip Partners LLP
 TranScrip Partners LLP Pharmaceuticals: MajorHealth Technology TranScrip Partners LLP is a consultancy provider for biotech and pharmaceutical companies. TranScrip Partners was founded in 2008 and is based in Wokingham, UK. The British company offers development and commercialization services to its clients. | Corporate Officer/Principal | - |
| Astra Draco AB | Technik-/Wissenschafts-/F&E-Leiter | - |
| CANTARGIA AB | Direktor/Vorstandsmitglied | - |
Forskarpatent i Syd AB
 Forskarpatent i Syd AB Miscellaneous Commercial ServicesCommercial Services Forskarpatent i Syd AB specialises in the commercialisation, through licensing or new venture spinouts, of patentable inventions emanating mainly from Swedish universities. It holds a portfolio of projects in the format of shares in spinouts, partnered (licensed) and still unpartnered assets. It is involves in projects in pharmaceutical, technology, and food categories. The firm is categorized under patent agency operations. The company was founded on January 18, 1996 and is headquartered in Lund, Sweden. | Direktor/Vorstandsmitglied | - |
| Cardio Vax LLC | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| WNTRESEARCH AB | Health Technology |
| CANTARGIA AB | Health Technology |
| Private Unternehmen | 7 |
|---|---|
| Astra Draco AB | |
Forskarpatent i Syd AB
Forskarpatent i Syd AB Miscellaneous Commercial ServicesCommercial Services Forskarpatent i Syd AB specialises in the commercialisation, through licensing or new venture spinouts, of patentable inventions emanating mainly from Swedish universities. It holds a portfolio of projects in the format of shares in spinouts, partnered (licensed) and still unpartnered assets. It is involves in projects in pharmaceutical, technology, and food categories. The firm is categorized under patent agency operations. The company was founded on January 18, 1996 and is headquartered in Lund, Sweden. | Commercial Services |
| Cardio Vax LLC | |
Ellet Assets AB
Ellet Assets AB Miscellaneous Commercial ServicesCommercial Services Ellet Assets AB owns and manages real estate properties and securities. The company is headquartered in Lund, Sweden. | Commercial Services |
TranScrip Partners LLP
TranScrip Partners LLP Pharmaceuticals: MajorHealth Technology TranScrip Partners LLP is a consultancy provider for biotech and pharmaceutical companies. TranScrip Partners was founded in 2008 and is based in Wokingham, UK. The British company offers development and commercialization services to its clients. | Health Technology |
| AstraZeneca R & D Lund | |
| Fastighets AB Olshög |
